CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction.
Gonzalo Núñez-MarínPatricia PalauEloy DomínguezRafael de la EspriellaLaura LópezCristina FlorPaloma MarínMiguel LorenzoGema MinanaVicent BodíJuan Sanchis ForésJulio NunezPublished in: Clinical kidney journal (2024)
In patients with stable HFpEF, NT-proBNP was not associated with maximal functional capacity when CKD was present. CA125 emerged as a useful biomarker for estimating effort intolerance in HFpEF irrespective of the presence of CKD.